Düsseldorf The future Bayer boss Bill Anderson starts his career with the Leverkusen group with great advance praise. On the day after the appointment of the 56-year-old as the new CEO, in addition to congratulations from competitors, there was a lot of praise from investors in particular for the appointment of the American, who will join Bayer from pharmaceutical company Roche. Bayer stock has gained a good six percent since Wednesday evening.
“It is exactly the right signal that an external and foreign CEO is moving to the top of Bayer,” said Marc Tüngler, general manager of the German Association for the Protection of Securities (DSW), the Handelsblatt.
“Bill Anderson has the chance to be able to turn every stone at Bayer completely unencumbered,” he said. “He can tackle changes without pulling the handbrake, as would have been the case with an internal successor.”
Bayer: High expectations of Anderson
Read on now
Get access to this and every other article in the
Web and in our app free of charge for 4 weeks.
Further
Read on now
Get access to this and every other article in the
Web and in our app free of charge for 4 weeks.
Further